Stocks were rising Wednesday and tech shares led the charge higher following better-than-expected earnings from Salesforce ...

The randomized clinical trial showed that Zepbound patients achieved 47% more relative weight loss than Wegovy patients.

Eli Lilly shares rose nearly 1.6% on Wednesday morning to three-week highs after the company unveiled promising results from ...

Eli Lilly & Co. Inc.'s stock (LLY) rose 2.3% Wednesday, after the company said its Zepbound weight-loss drug was more effective than rival Novo Nordisk's Wegovy in a head-to-head study.

Eli Lilly & Co. Inc.’s stock rose 1.5% early Wednesday, after the company said its Zepbound weight-loss drug was more effective than rival Novo Nordisk’s Wegovy in a head-to-head study. Zepbound ...

The well-received results from Salesforce.com are having an outsized impact on the Dow -- the software maker's current ...

Ozempic and Wegovy might be making it harder for physicians to guide patients toward lifestyle changes − the real key to long ...

LSU football was handed a gut-wrenching loss in Week 11 by No. 11 Alabama, a loss that significantly impacted its College Football Playoff odds and path. Already dealing with a small room for ...

Khloé Kardashian says losing weight has made her ‘more insecure.’ Here's why Khloé Kardashian is opening up about how her ...

Reality TV star Khloé Kardashian opened up about her fitness journey and shared her candid thoughts on one weight loss trend.

Amy Tapper, who rose to fame as a teen on Gogglebox, shared that she'd reached a major target on her weight loss journey ...